MARKET

PHVS

PHVS

Pharvaris N.V.
NASDAQ
35.25
-0.41
-1.15%
After Hours: 35.87 +0.62 +1.76% 19:43 09/04 EDT
OPEN
35.36
PREV CLOSE
35.66
HIGH
36.39
LOW
35.21
VOLUME
483.98K
TURNOVER
--
52 WEEK HIGH
38.13
52 WEEK LOW
20.65
MARKET CAP
2.47B
P/E (TTM)
-11.7897
1D
5D
1M
3M
1Y
5Y
1D
Will Positive Phase 3 Deucrictibant Data in HAE Redefine Pharvaris' (PHVS) Orphan-Drug Narrative
Simply Wall St · 5h ago
Pharvaris Presents Translational, Nonclinical, and Clinical Data at Bradykinin Symposium 2026
Barchart · 2d ago
Monthly top ideas from Oppenheimer include MA, MRVL, CMG, and more
Seeking Alpha · 3d ago
Pharvaris (PHVS) Gets a Buy from Morgan Stanley
TipRanks · 5d ago
Weekly Report: what happened at PHVS last week (0824-0828)?
Weekly Report · 5d ago
Buy Rating Reaffirmed as Deucrictibant Advances Toward Key Phase 3 Readout; $52 Price Target Maintained
TipRanks · 08/28 18:25
Biotech Stocks At 52-Week Highs - VOGX, PHVS, SOLV, IKT, HTFL
NASDAQ · 08/25 08:00
Pharvaris (PHVS) Receives a Buy from Morgan Stanley
TipRanks · 08/24 12:16
More
About PHVS
Pharvaris NV is a Netherlands-based company primarily engaged in the biopharmaceutical industry. The Company focuses on developing oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks. Their key product is Deucrictibant (PHA121, PHA-022121), which is a small-molecule bradykinin B2 receptor antagonist. It is intended for both the on-demand and prophylactic treatment of HAE attacks. Deucrictibant has been studied in vitro, ex vivo, and in vivo models to assess its effectiveness in blocking the bradykinin B2 receptor. The Company is developing deucrictibant for on-demand use as PHVS416, a softgel capsule, and for prophylactic use as PHVS719, an extended-release tablet.

Webull offers Pharvaris NV stock information, including NASDAQ: PHVS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHVS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PHVS stock methods without spending real money on the virtual paper trading platform.